Sintez

Sintez is one of the largest pharmaceutical companies in Russia, producing active pharmaceutical substances, finished dosage forms, veterinary drugs, and medical products made of polymeric materials. It is a leader in the production of antibiotics in Russia. The company is part of Binnopharm Group.

The company's shares are not listed. Trading is carried out on the MOEX OTC market. Purchase of shares is available only to qualified investors.

P/E

Net profit

P/B

Book value

Debts

Net debt

Yield

Growth potential

Report period	2019	2020	2021	2022	2023	Q2 24
End date of the reporting period
Capitalization, ₽
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Total preferered shares
Ordinary share price
Preferered share price

Report period	2019	2020	2021	2022	2023	Q2 24 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
EPS

Report period	2019	2020	2021	2022	2023	Q2 24 TTM
P/E
E/P
P/B
P/S
L/A
Debt-To-Equity
Net Debt/EBITDA
EV/EBITDA

Report period	2019	2020	2021	2022	2023	Q2 24 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin

Ticker	Name	Type	Nominal value	ISIN	Price
KSINP:RM	Sintez	Preferred share	RUB 1	RU0006571866	RUB 41,950
KSIN:RM	Sintez	Common share	RUB 1	RU0009257182	RUB 49,620

General information

Company name	Sintez
Tags	#pharmacy, #moex otc
Sector	Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals
Business address	g.Kurgan, pr. Konstitucii, d.7
Mailing address	640008, g.Kurgan, pr. Konstitucii, d.7
Website	www.ksintez.ru
Information disclosure	e-disclosure.ru

Sintez

Sintez balance sheet

Sintez cash flows

Sintez multipliers

Sintez profitability

Sintez shares